Real-world biologics response and super-response in the International Severe Asthma Registry cohort
Denton E, Hew M, Peters MJ, et al. Allergy. 2024; 00: 1-17. doi:10.1111/all.16178 Abstract Background Biologic asthma therapies reduce exacerbations and long-term oral corticosteroids (LTOCS) use in randomized controlled trials (RCTs); however, there are limited data on outcomes among…